Compare MCK & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCK | GSK |
|---|---|---|
| Founded | 1833 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.4B | 95.3B |
| IPO Year | N/A | N/A |
| Metric | MCK | GSK |
|---|---|---|
| Price | $819.05 | $48.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 1 |
| Target Price | ★ $882.69 | N/A |
| AVG Volume (30 Days) | 868.8K | ★ 4.0M |
| Earning Date | 02-04-2026 | 02-04-2026 |
| Dividend Yield | 0.40% | ★ 3.41% |
| EPS Growth | 66.19 | ★ 118.57 |
| EPS | ★ 32.12 | 1.79 |
| Revenue | ★ $387,094,000,000.00 | $43,237,357,842.00 |
| Revenue This Year | $14.87 | $6.56 |
| Revenue Next Year | $8.32 | $5.13 |
| P/E Ratio | $25.54 | ★ $13.24 |
| Revenue Growth | ★ 17.23 | 2.73 |
| 52 Week Low | $565.75 | $31.72 |
| 52 Week High | $895.58 | $49.44 |
| Indicator | MCK | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 55.99 |
| Support Level | $801.21 | $48.52 |
| Resistance Level | $824.95 | $49.44 |
| Average True Range (ATR) | 16.74 | 0.64 |
| MACD | -2.27 | -0.09 |
| Stochastic Oscillator | 45.20 | 61.57 |
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.